Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis

Autor: Jean-Michel Pochet, Anaïs Scohy, Laura Labriola, Gaëlle Gillerot, Manuel De Schuiteneer, Pauline Biller, Gaetan Clerbaux, Jean Cyr Yombi, Arnaud Robert, Hector Rodriguez-Villalobos, Johann Morelle, Benoit Kabamba, Elliott Van Regemorter, Michel Jadoul

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 78, no. 5, p. 766-768 (2021)
American journal of kidney diseases, Vol. 78, no. 5, p. 766-768 (2021)
American Journal of Kidney Diseases

TO THE EDITORS, We recently reported that almost all maintenance hemodialysis (MHD) patients mount specific antibodies within a month of COVID-19 onset. However, evidence concerning the immunogenicity of SARS-CoV-2 vaccines in this immunodeficient po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4efcb1dd2657c9cecc28a8f17af188f1
https://hdl.handle.net/2078.1/259740